Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 EPS, expectations were $1.85. Operator: Thank you for standing by. Welcome to ...
But rates of types 31/33/45, 47, and 45 were lower in vaccinated women, which the authors said suggests that the vaccines ...
The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is ...
Merck reported a 2% decline in Gardasil sales, after reaching a peak of $8.9 billion in 2023. Now with shipments to China paused, the HPV vaccine faces significant headwinds going into 2025.
Merck’s problems in China seem to be getting worse, raising questions about the company’s growth. Trouble with sales of Merck ...
Shares surged more than 22% on the strong results and outlook. The earnings report follows a historic rally in the company's ...
Kennedy played a key role in creating the mass lawsuit against Merck over the Gardasil vaccine from plaintiffs who allege it had severe side effects, according to Reuters. WisnerBaum is now one of ...
Kennedy played a key role in creating the mass lawsuit against Merck over the Gardasil vaccine from plaintiffs who allege it had severe side effects, according to Reuters. WisnerBaum is now one of the ...
Top of the morning to you, and a fine one it is, although we confess it is a bit frigid here on the Pharmalot campus. Even the official mascots are spending less time foraging for breakfast.
Jan 18 (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los ...
As the company faces criticism for its decision last year to not renew insurance policies for 72,000 property owners in California, State Farm has nixed plans to run a commercial during this year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results